Impact of Autologous Stem Cell Transplantation on Blood Pressure and Renal Function in Multiple Myeloma Patients

National Medical Association. Journal

JoshuaFogel¹  CameliaArsene, , M.H.S.²  ChadiSaad³  LeahBalsam³ 

[1] Department of Business Management, Brooklyn College, Brooklyn, NY, USA;Department of Medicine, Sinai-Grace Hospital, Detroit Medical Center/Wayne State University, Detroit, MI, USA;Division of Nephrology, Nassau University Medical Center, East Meadow, NY, USA

关键词: Hypertension;    Multiple myeloma;    Chronic kidney failure;    Kidney diseases;    Stem cell transplantation;   

DOI  :  10.1016/j.jnma.2017.02.010

学科分类：医学（综合）

来源: Elsevier

【 摘 要 】

BackgroundAutologous stem cell transplantation (ASCT) reverses kidney failure in one-third of multiple myeloma (MM) patients, which may lead to blood pressure (BP) improvement. We evaluate the long term impact of ASCT on BP and renal function in MM patients.

【 授权许可】

Unknown